BE852416A - Procede de purification et d'isolation du virus de l'hepatite en vue de l'utiliser dans la preparation de vaccins - Google Patents

Procede de purification et d'isolation du virus de l'hepatite en vue de l'utiliser dans la preparation de vaccins

Info

Publication number
BE852416A
BE852416A BE175747A BE175747A BE852416A BE 852416 A BE852416 A BE 852416A BE 175747 A BE175747 A BE 175747A BE 175747 A BE175747 A BE 175747A BE 852416 A BE852416 A BE 852416A
Authority
BE
Belgium
Prior art keywords
vaccines
purifying
isolating
procedure
preparation
Prior art date
Application number
BE175747A
Other languages
English (en)
Original Assignee
Kabi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Ab filed Critical Kabi Ab
Publication of BE852416A publication Critical patent/BE852416A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BE175747A 1976-03-18 1977-03-14 Procede de purification et d'isolation du virus de l'hepatite en vue de l'utiliser dans la preparation de vaccins BE852416A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7603386A SE420977B (sv) 1976-03-18 1976-03-18 Forfarande for rening och isolering av hepatitvirus for vaccinframstellning

Publications (1)

Publication Number Publication Date
BE852416A true BE852416A (fr) 1977-07-01

Family

ID=20327330

Family Applications (1)

Application Number Title Priority Date Filing Date
BE175747A BE852416A (fr) 1976-03-18 1977-03-14 Procede de purification et d'isolation du virus de l'hepatite en vue de l'utiliser dans la preparation de vaccins

Country Status (10)

Country Link
US (1) US4138287A (fr)
JP (1) JPS52114018A (fr)
AU (1) AU506385B2 (fr)
BE (1) BE852416A (fr)
CA (1) CA1073815A (fr)
DE (1) DE2711773A1 (fr)
FR (1) FR2344629A1 (fr)
GB (1) GB1511997A (fr)
NL (1) NL7702784A (fr)
SE (1) SE420977B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4181713A (en) * 1978-10-30 1980-01-01 Merck & Co., Inc. Isolation of HBs Ag
US6297355B1 (en) 1978-12-22 2001-10-02 Biogen, Inc. Polypeptides displaying HBV antigenicity or hbv antigen specificity
US4242324A (en) * 1979-04-04 1980-12-30 Merck & Co., Inc. Hepatitis B antigen
US4395395A (en) * 1979-05-21 1983-07-26 The United States Of America As Represented By The Department Of Health And Human Services Detection of non-A, non-B hepatitis associated antigen
PL133476B1 (en) * 1981-06-10 1985-06-29 Akad Medyczna Method of obtaining pure antigen hba from human serum
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
US4603112A (en) * 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US7767449B1 (en) * 1981-12-24 2010-08-03 Health Research Incorporated Methods using modified vaccinia virus
US4511473A (en) * 1982-02-09 1985-04-16 Amf Incorporated Fibrous media containing millimicron-sized particulates
JPS59219239A (ja) * 1983-05-28 1984-12-10 Chemo Sero Therapeut Res Inst Ｂ型肝炎ウイルス表面抗原の精製方法
JPS59164727A (ja) * 1983-03-09 1984-09-17 Chemo Sero Therapeut Res Inst Ｂ型肝炎ウイルス表面抗原の精製方法
US4515714A (en) * 1983-03-09 1985-05-07 Juridicial Foundation, The Chemo-Semo-Sero-Therapeutic Research Institute Method for purification of hepatitis B virus surface antigen
US4563303A (en) * 1984-04-14 1986-01-07 Judicial Foundation The Chemosero-Therapeutic Research Institute Method for purification of filamentous hemagglutinin
JPS6147185A (ja) * 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst 日本脳炎ウイルスの精製方法
JPS6147186A (ja) * 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst インフルエンザウイルスの精製方法
JPS6147187A (ja) * 1984-08-10 1986-03-07 Chemo Sero Therapeut Res Inst 狂犬病ウイルスの精製方法
JPS6153226A (ja) * 1984-08-24 1986-03-17 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニツトワクチンの精製方法
JPS61103895A (ja) * 1984-10-26 1986-05-22 Green Cross Corp:The ＨＢｓＡｇの精製方法
SE503844C2 (sv) 1989-02-09 1996-09-16 Pharmacia Ab Förfarande för rening av streptokinaser
US5447859A (en) * 1993-07-16 1995-09-05 Viagene Method for the purification or removal of retroviruses using sulfated cellulose
JP3615785B2 (ja) * 1994-04-28 2005-02-02 テルモ株式会社 Ｈｉｖ及びその関連物質除去材料
GB9804632D0 (en) * 1998-03-05 1998-04-29 Cantab Pharma Res Virus preparations and methods
US6221855B1 (en) * 1999-03-11 2001-04-24 Wake Forest University Regulation of nucleic acid expression by heparan sulfate and biological equivalents thereof
AU2004249802B2 (en) * 2003-06-20 2007-06-28 Microbix Biosystems Inc. Improvements in virus production
JP2008501339A (ja) * 2004-06-01 2008-01-24 ジェンザイム・コーポレイション Ａａｖベクターの凝集を防ぐための組成物およびその方法
EP2066418A4 (fr) 2006-09-29 2011-12-28 Ge Healthcare Bio Sciences Ab Matrice de séparation pour une purification virale
CN114210310B (zh) * 2021-12-06 2023-09-29 武汉瑞法医疗器械有限公司 乙型肝炎病毒和HBsAg免疫吸附材料的制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process
US3925152A (en) * 1971-06-18 1975-12-09 Exploaterings Ab Tbf Virus separation
US3896218A (en) * 1972-07-13 1975-07-22 Research Corp Radiommunoassay determining the hepatitis associated antigen content of blood
US3994870A (en) * 1974-01-31 1976-11-30 The Community Blood Council Of Greater New York, Inc. Purification of hepatitis B surface antigen
US3976767A (en) * 1975-04-14 1976-08-24 The New York Blood Center Purification of hepatitis B surface antigen by chromatography on agarose containing aminoalkyl residues
IL49752A (en) * 1975-07-09 1979-07-25 Kabi Ab Compositions having affinity for hepatitis virus and method for hepatitis virus removal or concentration

Also Published As

Publication number Publication date
AU506385B2 (en) 1979-12-20
FR2344629A1 (fr) 1977-10-14
US4138287A (en) 1979-02-06
DE2711773A1 (de) 1977-09-22
SE420977B (sv) 1981-11-16
FR2344629B1 (fr) 1983-07-18
GB1511997A (en) 1978-05-24
CA1073815A (fr) 1980-03-18
JPS52114018A (en) 1977-09-24
NL7702784A (nl) 1977-09-20
SE7603386L (sv) 1977-09-19
AU2331377A (en) 1978-09-21

Similar Documents

Publication Publication Date Title
BE852416A (fr) Procede de purification et d'isolation du virus de l'hepatite en vue de l'utiliser dans la preparation de vaccins
IT1127253B (it) Proteine purificate e procedimento per la loro preparazione
DK674389D0 (da) Anvendelse af nalmefen eller naltrexon til fremstilling af et laegemiddel til behandling af artritiske og inflammatoriske sygdomme
NZ193487A (en) Purification of human le form interferon proteins and antibodies thereto
NO152635C (no) Fremgangsmaate for fremstilling av cyklosporinholdige farmasoeytiske preparater i flytende form
BE860712A (fr) Polyurethannes dispersables dans l'eau et leur procede de preparation
NL930132I1 (nl) Vaccin tegen hepatitis B virus werkwijze en getransformeerde eukaryotische cellen en de bereiding van dat vaccin
ES290656Y (es) Dispositivo para recoger y mantener vivos los cultivos del cuerpo del paciente.
LU79477A1 (fr) Procedes de preparation de l'antigene du noyau d'hepatite b et de vaccins le contenant
DK169986A (da) Antigen beslaegtet med glycoproteinet i aids-virus, isaer en praekursor for glycoproteinet, og fremgangsmaade til fremstilling af et saadant antigen
JPS54126596A (en) Method of detecting or fixing virus antigen or red blood* bacteria antigen or antigen
KR890700662A (ko) 바이러스 항원과 그의 제조방법 및 진단과 치료를 목적으로 하는 사용방법
PT75066B (en) Process for the preparation of new cephem compounds useful in the treatment of infectious diseases in human being and animals
AU530526B2 (en) Preparation and use of 195m au-containing liquid
PT97749A (pt) Processo para a preparacao de composicoes farmaceuticas contendo dsarn apropriadas para o diagnostico e o tratamento de hepatite viral
MX155164A (es) Procedimiento mejorado para la recuperacion y purificacion de acrilonitrilo
JPS55153723A (en) Manufacture of influenza virus vaccine in liquid cell culture
ZA813479B (en) Process for the isolation of viral glycoproteic antigens and its application to the preparation of vaccines
IT1104828B (it) Procedimento e dispositivo per la depurazione di sostanze solide in particolare di silicio
PT70556A (en) Vaccines against diseases caused by reo-virus and process for the preparation of those vaccines
RO77284A (fr) Procede pour la preparation et la purification des resines epoxydes
JPS53139714A (en) Method for separating interferon active substance from medical preparation containing said substace and purifying same * purified substance and utilizing same as medicine
FR2587898B2 (fr) Moyen de contention des enfants et adultes pour realiser certains actes medicaux ou leur transport
IT8068995A0 (it) Procedimento per la preparazione di medicamenti e di agenti di disattivazione dei microorganismi
JPS563062A (en) Filtering and dialyzing membrane for circulation at outside of body